- Home
- DERM vs LUCD Comparison
DERM vs LUCD Comparison
Compare DERM & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- LUCD
- Stock Information
- Founded
- DERM 2014
- LUCD 2018
- Country
- DERM United States
- LUCD United States
- Employees
- DERM N/A
- LUCD N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DERM Health Care
- LUCD Health Care
- Exchange
- DERM Nasdaq
- LUCD Nasdaq
- Market Cap
- DERM 107.4M
- LUCD 119.7M
- IPO Year
- DERM 2021
- LUCD 2021
- Fundamental
- Price
- DERM $6.11
- LUCD $1.58
- Analyst Decision
- DERM Strong Buy
- LUCD Strong Buy
- Analyst Count
- DERM 2
- LUCD 4
- Target Price
- DERM $10.00
- LUCD $3.75
- AVG Volume (30 Days)
- DERM 65.9K
- LUCD 904.7K
- Earning Date
- DERM 03-26-2025
- LUCD 03-24-2025
- Dividend Yield
- DERM N/A
- LUCD N/A
- EPS Growth
- DERM N/A
- LUCD N/A
- EPS
- DERM N/A
- LUCD N/A
- Revenue
- DERM $56,134,000.00
- LUCD $4,346,000.00
- Revenue This Year
- DERM N/A
- LUCD $156.40
- Revenue Next Year
- DERM $36.49
- LUCD $206.37
- P/E Ratio
- DERM N/A
- LUCD N/A
- Revenue Growth
- DERM N/A
- LUCD 79.00
- 52 Week Low
- DERM $3.20
- LUCD $0.63
- 52 Week High
- DERM $6.89
- LUCD $1.63
- Technical
- Relative Strength Index (RSI)
- DERM 60.90
- LUCD 62.35
- Support Level
- DERM $5.51
- LUCD $1.43
- Resistance Level
- DERM $6.84
- LUCD $1.60
- Average True Range (ATR)
- DERM 0.43
- LUCD 0.12
- MACD
- DERM 0.05
- LUCD 0.01
- Stochastic Oscillator
- DERM 60.65
- LUCD 95.24
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.